We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 47

Costs of patent amendment application not immutable; opponent ordered to pay substantial legal costs
  • Davies Collison Cave
  • Australia
  • May 4 2015

Departing from the near 'immutable rule' that the amending party pay any other party's legal costs of the amendment


Damages recovery by the Commonwealth pursuant to the “usual undertakings”
  • Davies Collison Cave
  • Australia
  • April 29 2015

A recent procedural decision by Nicholas J in the Federal Court provides an interesting snapshot of the issues involved in the recovery of damages by


LG’s comparative advertisement with Samsung for 3D TV was misleading
  • Davies Collison Cave
  • Australia
  • April 28 2015

Samsung issued proceedings against LG for misleading or deceptive conduct and the tort of injurious falsehood in relation to six television


Intellectual Property Laws Amendment Act 2015 update on recent changes to Australia’s intellectual property legislation
  • Davies Collison Cave
  • Australia, New Zealand
  • April 15 2015

The Intellectual Property Laws Amendment Act 2015 (Cth) received Royal Assent on 25 February 2015. Although some changes under the Act came into


Isolated gene sequences are patentable in Australia
  • Davies Collison Cave
  • Australia, USA
  • September 8 2014

In a decision handed down on Friday 5 September 2014 a Full Federal Court consisting of 5 Justices affirmed the decision of Nicholas J at first


Maximising a patentee's legal costs recovery in successful patent litigation
  • Davies Collison Cave
  • Australia
  • June 13 2014

Section 19 of the Patents Act 1990 (Cth) arises infrequently in practice, but its provisions can be of real value to a patentee, as was shown in


Pharmaceutical generic patent indirect infringement victory overturned
  • Davies Collison Cave
  • Australia
  • May 21 2014

In a unanimous decision handed down on 19 May 2014 in Warner-Lambert Co LLC v Apotex Pty Ltd 2014 FCAFC 59 (Warner-Lambert), the Full Court made it


TGA's guidance on clinical trial data and commercially confidential information
  • Davies Collison Cave
  • Australia
  • May 20 2014

The Therapeutic Goods Administration (TGA) recently undertook a review of its treatment of commercially confidential information (CCI), and published


Federal Court confirms "key-hole arrangement" patent lacks inventive step
  • Davies Collison Cave
  • Australia, Canada
  • February 24 2014

Justice Robertson of the Federal Court of Australia has recently dismissed an appeal against the Commissioner of Patent's finding that key claims of a


Australian government seeks to bolster powers under Therapeutic Goods legislation
  • Davies Collison Cave
  • Australia
  • February 13 2014

In December 2013, the Minister for Health introduced the Therapeutic Goods Amendment (2013 Measures No.1) Bill 2013 (the Bill) into Parliament. The